Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
153-Samarium-EDTMP + Melphalan Conditioning for PBSCT in Multiple Myeloma
NCT00602706Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2000
- Primary completion
- Jun 2003
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of samarium-153 lexidronam in multiple myeloma (MM), sponsored by Mayo Clinic. Started Jan 2000; status: completed.
02
Drugs
samarium-153 lexidronam
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00602706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00602706.